COVID-19 Serology Data Provide Guidance for Future Deployments of Convalescent Plasma-Reference-Cited by-同舟云学术

COVID-19 Serology Data Provide Guidance for Future Deployments of Convalescent Plasma

Published:2023-06-27 Issue:3 Volume:14 Page:
ISSN:2150-7511
Container-title:mBio
language:en
Short-container-title:mBio

Author:

Sullivan David¹^ORCID,Casadevall Arturo¹^ORCID

Affiliation:

1. Department of Molecular Microbiology, Johns Hopkins School of Public Health, Baltimore, Maryland, USA

Abstract

Measurement of antibody content and function after a viral illness is important for diagnosis and selection of the best convalescent plasma (CP) units for passive immunization. Zhang et al. (mBio 14:e03523-22, 2013, https://doi.org/10.1128/mbio.03523-22 ) analyzed over 19,000 coronavirus disease 2019 (COVID-19) CP (CCP) samples from the early days of the COVID-19 pandemic and reported a moderately strong correlation between antibody amount and neutralizing titer.

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mbio.00428-23

Reference30 articles.

1. Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study

2. Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality

3. High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020

4. SARS-CoV-2 (COVID-19) by the numbers

5. Humoral Innate Immunity and Acute-Phase Proteins

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of convalescent plasma and hyperimmune immunoglobulins in the COVID-19 pandemic, including implications for future preparedness;Frontiers in Immunology;2024-09-09

2. Estimates of Actual and Potential Lives Saved in the United States from the use of COVID-19 Convalescent Plasma;2024-05-18

3. Generating the Evidence Base for Convalescent Plasma Use for a New Infectious Disease;Current Topics in Microbiology and Immunology;2024

4. Convalescent Plasma and Other Antibody Therapies for Infectious Diseases—Lessons Learned from COVID-19 and Future Prospects;Current Topics in Microbiology and Immunology;2024

5. Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy;Expert Review of Respiratory Medicine;2023-05-02